Back to issues of risk…
Last week I posted about how difficult it is sometimes to understand about risk, especially to distinguish between absolute risk and relative risk. Today I read the “Second Opinion” column in the...
View ArticleScreening for Prostate Cancer- PSA Testing or Not??
In an official move that should have come as no surprise to anyone, the United States Preventive Services Task Force (USPSTF) published a very controversial recommendation in the Annals of Internal...
View ArticleCancers: To Screen; Perchance to Treat?
Although this post does not fall in the category of “breaking” news, the subject matter is so important in the context of today’s cancer research, diagnosis and treatment that I think it is worthwhile...
View ArticleDr. Oz: A Case of Celebrity Run Amok??
Cancer Research 101 is all about cancer research (duh!) and I have tried studiously to keep it that way. After all, that’s where my expertise lies, and while I have opinions about a million other...
View ArticleCanada’s Shame: Asbestos Hypocrisy
I seem to be on an bit of an “editorial” rant these days. First it was Canada’s pharmaceutical industry and its failure to live up to its legislated obligations on R&D spending in return for patent...
View ArticleAllowing Fear to Dictate Cancer Treatment Decisions
Last week saw the publication of a study on ductal carcinoma in situ. It engendered a lot of mixed messages as I wrote about here. Following on from that study, also last week (August 27, 2015) the...
View Article